Ignite Creation Date:
2025-12-26 @ 12:18 PM
Ignite Modification Date:
2026-03-10 @ 10:51 AM
Study NCT ID:
NCT03218800
Status:
TERMINATED
Last Update Posted:
2022-08-11
First Post:
2017-07-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ertapenem Administered Subcutaneously Versus Intravenously
Sponsor:
Instituto Nacional de Cancer, Brazil
Organization:
Organization Data
Organization:
Class:
OTHER_GOV
Study ID:
Ertapsubcut
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None